Reporting quality of randomized controlled trials evaluating non-vitamin K oral anticoagulants in atrial fibrillation: a systematic review
Abstract Background Randomized controlled trials (RCTs) are subject to bias if they lack methodological quality. Furthermore, optimal and transparent reporting of RCT findings aids their critical appraisal and interpretation. This study aimed to comprehensively evaluate the report quality of RCTs of...
Main Authors: | YueGuang Yang, YuBo Han, GuoLiang Zou, YanBo Sui, Juan Jin, Li Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12872-023-03258-z |
Similar Items
-
What is the quality of reporting in randomized controlled trials in spinal conditions
by: Andreas K Demetriades, et al.
Published: (2023-01-01) -
New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01) -
Where will non-Vitamin K oral anticoagulants stand beyond being standard of care in anticoagulation therapy?
by: Oktay Ergene
Published: (2019-01-01) -
Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
by: Pedro Silva Cunha, et al.
Published: (2022-02-01) -
Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)